Matthew J. Paul
- Biotechnology top 0.5%
- Transgenic Plants and Applications 24
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Immune responses and vaccinations 5
- Immune Cell Function and Interaction 4
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 8
-
- CRISPR and Genetic Engineering 13
- Plant tissue culture and regeneration 12
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Julian K‐C.Rajko ReljićPascal M. W. DrakeCraig J. van DolleweerdAlastair CoplandElena StylianouAudrey Y‐H. TehPeter Hart
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Matthew J. Paul
43 papers receiving 968 citations
Peers
Comparison fields: 5 of 74
- Biotechnology 591
- Immunology 369
- Infectious Diseases 230
- Molecular Biology 572
- Radiology, Nuclear Medicine and Imaging 116
Countries citing papers authored by Matthew J. Paul
This map shows the geographic impact of Matthew J. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Paul more than expected).
Fields of papers citing papers by Matthew J. Paul
This network shows the impact of papers produced by Matthew J. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Paul. The network helps show where Matthew J. Paul may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew J. Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 46 | |
| 9 | 2015 | 21 | |
| 10 | 2015 | 4 | |
| 11 | 2014 | 45 | |
| 12 | 2013 | 42 | |
| 13 | 2013 | 45 | |
| 14 | 2013 | 19 | |
| 15 | 2012 | 3 | |
| 16 | 2011 | 116 | |
| 17 | 2011 | 45 | |
| 18 | 2011 | 29 | |
| 19 | 2010 | 21 | |
| 20 | 2009 | 29 |
About Matthew J. Paul
Matthew J. Paul is a scholar working on Biotechnology, Immunology and Infectious Diseases, having authored 43 papers that have together received 983 indexed citations. Recurring topics across this work include Transgenic Plants and Applications (24 papers), CRISPR and Genetic Engineering (13 papers), Plant tissue culture and regeneration (12 papers), Tuberculosis Research and Epidemiology (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (6 papers), Immune responses and vaccinations (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Biotechnology (591 citations), Immunology (369 citations) and Infectious Diseases (230 citations). Matthew J. Paul has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Julian K‐C., Rajko Reljić, Pascal M. W. Drake, Craig J. van Dolleweerd, Alastair Copland, Elena Stylianou, Audrey Y‐H. Teh, Peter Hart, Harry Thangaraj and Ilaria Pepponi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.